Genetically-Enhanced Mesenchymal stem cells (GEM)

DRUG/DEVICE

Allogeneic human Mesenchymal Stem Cells (MSCs) modified with gene transfer.

ROUTE OF ADMINISTRATION

Intravenous

THERAPEUTIC PLATFORM

NCE / Novel Biologics

TERRITORY

Canadian Study; United States license

STATUS

Pre-clinical

(Targeting to initiate CTA with Health Canada in 2020)

Genetically-Enhanced MSC (GEM) is a development-stage product not approved for sale in any jurisdiction.